Thaidex SET High Dividend ETF (1DIV)
SET SET Primary Summary
1DIV Chart
Thaidex SET High Dividend ETF (1DIV) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Thaidex SET High Dividend ETF ever had a stock split?
Thaidex SET High Dividend ETF Profile
| SET Exchange | Austria Country |
Overview
Marinomed Biotech AG is a pioneering biopharmaceutical company based in Austria that concentrates on developing innovative therapeutic solutions primarily targeting conditions related to virology and immunology. The company's operations are divided into three key segments: Virology, Immunology, and Other, with its activities extending throughout Europe and on an international scale. Originally named Marinomed Biotechnologie GmbH, the company underwent a name change to Marinomed Biotech AG in June 2017 and was founded in 2006. Its main office is situated in Korneuburg, Austria. Marinomed Biotech AG has established itself as a leader in its field through significant technology partnerships, notably with SPH Sine Pharmaceutical Laboratories Co. Ltd., further strengthening its research and development capabilities.
Products and Services
- Budesolv - This innovative therapy is devised for the treatment of allergic rhinitis. By providing a novel approach, Budesolv aims to alleviate symptoms linked with this common allergic condition, offering relief to countless sufferers globally.
- Tacrosolv - Currently in Phase II clinical trials, Tacrosolv is being developed for treating inflammatory eye diseases. This product highlights Marinomed Biotech AG's dedication to addressing and improving eye health through advanced therapeutic options.
- Carravin - Designed to treat nasal congestion, Carravin represents Marinomed's commitment to providing solutions for respiratory conditions. Through Carravin, Marinomed offers an innovative approach to managing and relieving nasal congestion symptoms.
- Inhaleen - This product is under development for viral pneumonia, a serious respiratory condition. Inhaleen demonstrates Marinomed Biotech AG's ongoing efforts to combat and mitigate the impacts of viral infections on the respiratory system.
- Carragelose - A versatile product consisting of nasal and throat sprays, and lozenges, Carragelose is developed for the treatment of viral respiratory infections. Its unique formulation is crafted to offer relief and protection against various viruses responsible for respiratory illnesses.
